Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 3 7Phase 1/2 5Phase 1 5Phase NA 2Phase 4 1Phase 2/3 1

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1Advanced Breast Cancer 1

Interventions

Exercise 57Radiotherapy 49Blood Specimen Collection 45Radiosurgery 35Drug Therapy 33Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19Control Groups 19camrelizumab 16Propofol 16Metformin 16Cytarabine 16Surveys and Questionnaires 15Preoperative Exercise 15Injections 15Fluorouracil 15anlotinib 14Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Unknown × Fulvestrant × Clear all
NCT05047848 2021-09-17

Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

Liaoning Cancer Hospital & Institute

Phase NA Unknown
82 enrolled
Breast

Advanced Breast Cancer

NCT00126464 2013-11-06

Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

National Cancer Institute (NCI)

Phase NA Unknown
100 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡